Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,803 | 68,204 | 73,306 | 104,713 | 60,392 |
| Receivables | 145 | 145 | 58 | 79 | N/A |
| TOTAL | $44,087 | $70,297 | $80,276 | $106,105 | $60,816 |
| Non-Current Assets | |||||
| PPE Net | 531 | 801 | 1,994 | 1,141 | 253 |
| Other Non-Current Assets | 619 | 656 | 1,134 | 862 | 451 |
| TOTAL | $1,150 | $1,457 | $3,128 | $2,003 | $704 |
| Total Assets | $45,237 | $71,754 | $83,404 | $108,108 | $61,520 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,004 | 422 | 1,509 | 1,727 | 1,031 |
| Accrued Expenses | 7,182 | 6,357 | 16,516 | 10,821 | 2,538 |
| TOTAL | $10,826 | $7,791 | $18,864 | $13,363 | $3,612 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,640 | 1,012 | 839 | 815 | 43 |
| Other Non-Current Liabilities | 0 | 11,796 | 12,962 | 19,425 | 27,311 |
| TOTAL | $570 | $14,580 | $16,095 | $23,138 | $27,355 |
| Total Liabilities | $11,396 | $22,371 | $34,959 | $36,501 | $30,967 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 765 | 671 | 558 | 530 | 439 |
| Common Shares | 104 | 100 | 83 | 69 | 48 |
| Retained earnings | -372,612 | -340,831 | -283,724 | -187,592 | -123,814 |
| TOTAL | $33,841 | $49,383 | $48,445 | $71,607 | $30,553 |
| Total Liabilities And Equity | $45,237 | $71,754 | $83,404 | $108,108 | $61,520 |